Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
|Podcasts|December 17, 2020
S2E9: Linda Fan, MD, on telehealth in the second stage of COVID-19
Author(s)Lindsey Carr, Editor
Advertisement
This episode of Pap Talk features Linda Fan, MD, an assistant professor of Obstetrics, Gynecology, and Reproductive Sciences; Section Chief of Gynecology; and director of Gynecologic Quality and Safety at the Yale School of Medicine.
Advertisement
Related to this article
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Perimenopausal women who were more physically active had significantly lower symptom burden across all domains, a study of 1808 Flo app users found.
JoAnn V. Pinkerton, MD, MSCP, reviews 4 pooled elinzanetant analyses from OASIS presented at The Menopause Society Annual Meeting 2026, spanning late perimenopause, sleep, VMS reduction, and safety.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Perimenopausal women over-reported total sleep time by a mean of 35.3 minutes and under-reported wake time compared with Fitbit data.
Elinzanetant cut moderate-to-severe VMS frequency by ≥50% in 66.9% of US participants compared with 40.5% on placebo.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
JoAnn V. Pinkerton, MD, MSCP, on elinzanetant across menopause subpopulations at TMS 2026
3
Wearables may add insight into perimenopausal sleep complaints
4
Executive order directs NIH to create women's health division
5